GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gerresheimer AG (OTCPK:GRRMY) » Definitions » ROE % Adjusted to Book Value

GRRMY (Gerresheimer AG) ROE % Adjusted to Book Value : 3.45% (As of Aug. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Gerresheimer AG ROE % Adjusted to Book Value?

Gerresheimer AG's ROE % for the quarter that ended in Aug. 2024 was 7.55%. Gerresheimer AG's PB Ratio for the quarter that ended in Aug. 2024 was 2.19. Gerresheimer AG's ROE % Adjusted to Book Value for the quarter that ended in Aug. 2024 was 3.45%.


Gerresheimer AG ROE % Adjusted to Book Value Historical Data

The historical data trend for Gerresheimer AG's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gerresheimer AG ROE % Adjusted to Book Value Chart

Gerresheimer AG Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 4.02

Gerresheimer AG Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.70 5.22 1.35 3.78 3.45

Competitive Comparison of Gerresheimer AG's ROE % Adjusted to Book Value

For the Medical Instruments & Supplies subindustry, Gerresheimer AG's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gerresheimer AG's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gerresheimer AG's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Gerresheimer AG's ROE % Adjusted to Book Value falls into.



Gerresheimer AG ROE % Adjusted to Book Value Calculation

Gerresheimer AG's ROE % Adjusted to Book Value for the fiscal year that ended in Nov. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=8.88% / 2.21
=4.02%

Gerresheimer AG's ROE % Adjusted to Book Value for the quarter that ended in Aug. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=7.55% / 2.19
=3.45%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gerresheimer AG ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Gerresheimer AG's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Gerresheimer AG Business Description

Traded in Other Exchanges
Address
Klaus-Bungert-Strasse 4, Duesseldorf, NW, DEU, 40468
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.

Gerresheimer AG Headlines

From GuruFocus

Q1 2021 Gerresheimer AG Earnings Call Transcript

By GuruFocus Research 03-04-2024

Q2 2022 Gerresheimer AG Earnings Call Transcript

By GuruFocus Research 03-04-2024

Q2 2021 Gerresheimer AG Earnings Call Transcript

By GuruFocus Research 03-04-2024

Q2 2020 Gerresheimer AG Earnings Call Transcript

By GuruFocus Research 03-04-2024

Q3 2021 Gerresheimer AG Earnings Call Transcript

By GuruFocus Research 03-04-2024

Q3 2023 Gerresheimer AG Earnings Call Transcript

By GuruFocus Research 03-04-2024

Q4 2021 Gerresheimer AG Earnings Call Transcript

By GuruFocus Research 03-04-2024

Gerresheimer With Strong Second Quarter

By PRNewswire PRNewswire 07-14-2020

Q3 2022 Gerresheimer AG Earnings Call Transcript

By GuruFocus Research 03-04-2024